Synovus Financial Corp Abbott Laboratories Transaction History

Synovus Financial Corp

$9.33 Billion
Q3 2024

A detailed history of Synovus Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Synovus Financial Corp holds 161,678 shares of ABT stock, worth $18.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

161,678

Previous 164,995 2.01%

Holding current value

$18.6 Million

Previous $17.1 Million 7.51%

% of portfolio

0.2%

Previous 0.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $331,932 - $391,837	-3,317 Reduced 2.01%	161,678 $18.4 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $214,857 - $239,834	-2,133 Reduced 1.28%	164,995 $17.1 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $7.25 Million - $8 Million	-66,161 Reduced 28.36%	167,128 $19 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $457,779 - $549,259	-4,792 Reduced 2.01%	233,289 $22.6 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $105,516 - $117,567	-1,047 Reduced 0.44%	238,081 $26 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $312,664 - $368,024	-3,228 Reduced 1.33%	239,128 $24.2 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $775,024 - $909,222	8,153 Added 3.48%	242,356 $26.6 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $395,554 - $457,978	4,088 Added 1.78%	234,203 $22.7 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $175,050 - $211,579	1,715 Added 0.75%	230,115 $25 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $781,037 - $952,424	6,850 Added 3.09%	228,400 $27.1 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $3.15 Million - $3.86 Million	-27,290 Reduced 10.97%	221,550 $31.2 Million
Q3 2021 Nov 08, 2021	BUY	$116.66 - $129.06 $3.67 Million - $4.06 Million	31,473 Added 14.48%	248,840 $29.4 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $281,612 - $331,498	2,662 Added 1.24%	217,367 $25.2 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $295,609 - $348,272	-2,716 Reduced 1.25%	214,705 $25.7 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $336,525 - $366,716	3,205 Added 1.5%	217,421 $23.8 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $898,621 - $1.09 Million	-9,806 Reduced 4.38%	214,216 $23.3 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $4.52 Million - $5.79 Million	-59,039 Reduced 20.86%	224,022 $20.5 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $3.87 Million - $5.66 Million	61,615 Added 27.82%	283,061 $22.4 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $71,130 - $79,184	-906 Reduced 0.41%	221,446 $19.2 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $129,798 - $140,741	1,586 Added 0.72%	222,352 $18.6 Million
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $117,118 - $136,595	1,607 Added 0.73%	220,766 $18.6 Million
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $804,506 - $972,648	-12,149 Reduced 5.25%	219,159 $17.5 Million
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $128,825 - $145,940	1,965 Added 0.86%	231,308 $16.7 Million
Q3 2018 Nov 01, 2018	BUY	$60.81 - $73.36 $78,019 - $94,120	1,283 Added 0.56%	229,343 $16.8 Million
Q2 2018 Aug 01, 2018	BUY	$57.57 - $63.54 $276,393 - $305,055	4,801 Added 2.15%	228,060 $13.9 Million
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $214,613 - $242,646	-3,814 Reduced 1.68%	223,259 $13.4 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $38,327 - $41,033	714 Added 0.32%	227,073 $13 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $10.9 Million - $12.1 Million	226,359	226,359 $12.1 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Abbott Laboratories Transaction History